Keyphrases
New York City
100%
People Who Inject Drugs
51%
Syringe Services Programs
34%
HIV Infection
29%
Non-medical Use
26%
Herpes Simplex Virus 2 (HSV-2)
24%
Drug Users
21%
Hepatitis C Virus
21%
HIV Epidemic
20%
Syringe Exchange
18%
HIV Incidence
17%
Disparities in HIV
17%
AIDS/HIV
17%
Confidence Interval
14%
Injection Drug Users
14%
Injection Drug Use
14%
Hepatitis C Treatment
13%
Israel
12%
Drug Use
12%
People Who Use Drugs
11%
Opioid Epidemic
11%
HIV Prevalence
10%
HIV Transmission
10%
Risk Behavior
10%
Syrinx
10%
Hepatitis C Virus Infection
10%
Injectable Drugs
10%
Integrated Prevention
9%
New Injectors
9%
Cocaine
9%
High Prevalence
8%
Heroin
8%
Racial Disparities
8%
Crack Cocaine
8%
Viral Outbreaks
8%
Hispanic
8%
Heroin Users
8%
Cocaine Users
8%
Hepatitis C Virus Prevalence
7%
Adjusted Odds Ratio
7%
Heterosexual
7%
African American
7%
HIV Prevention
7%
Hepatitis C
7%
White People
7%
Drug Overdose
6%
HIV Risk
6%
Mount Sinai
6%
Methadone Maintenance Treatment
6%
Men Who Have Sex with Men
6%
Medicine and Dentistry
Human Immunodeficiency Virus
99%
Drug Use
46%
Prevalence
33%
Human Immunodeficiency Virus Infection
27%
Diamorphine
27%
Hepatitis C
25%
Hepatitis C Virus
23%
Odds Ratio
21%
Methadone Treatment
20%
COVID-19
19%
Non-Injecting Drug User
15%
Harm Reduction
14%
Drug Administration
14%
Ethnic Disparity
14%
Human Immunodeficiency Virus Prevalence
14%
Maintenance Therapy
13%
Gene Linkage
12%
Opiate
11%
Immigrant
11%
COVID-19 Vaccination
11%
Drug Therapy
10%
Substance Use
10%
Infection
10%
Care Coordination
9%
Hepatitis Virus
9%
Human Immunodeficiency Virus Risk Behavior
8%
Transgender
8%
Health Care Cost
8%
Health Outcomes
7%
Clinical Trial
7%
Narcotic Analgesic Agent
7%
Fentanyl
6%
Hepatitis A
6%
Cost-Effectiveness Analysis
6%
Herpes Simplex Virus 2
6%
Base
5%
Mental Health
5%
Geographic Distribution
5%
Hepatitis B Virus
5%
Systematic Review
5%
Quality Adjusted Life Year
5%
Men Who Have Sex with Men
5%
Marginalised Population
5%
Anodyne
5%
Hepatitis A Virus
5%
Social Support
5%
Drug Overdose
5%
Hepatitis C Treatment
5%
Epidemiology of Pain
5%
Health Care Utilization
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
80%
Prevalence
52%
Hepatitis C
41%
Diamorphine
38%
Human Immunodeficiency Virus Infection
31%
Methadone
30%
Hepatitis C Virus
27%
Herpes Simplex Virus 2
24%
Infection
21%
Illicit Drug
18%
Duragesic
17%
Vaccination Policy
17%
Virus Hepatitis
15%
Opiate
14%
Toxic Injury
14%
Drug Overdose
12%
Pharmacotherapy
10%
Human Immunodeficiency Virus Prevalence
9%
Disease
7%
Cocaine
7%
Narcotic Analgesic Agent
7%
Hepatitis A
6%
Clinical Trial
6%
Pandemic
6%
Hepatitis A Virus
6%
Hepatitis B Virus
6%
Cannabis
5%
Virus Infection
5%
Methadone Treatment
5%
Geographic Distribution
5%
Analgesic Agent
5%
Hepacivirus
5%
Hepatitis B
5%
Randomized Controlled Trial
5%